Submission for OMB Review; 30-Day Comment Request; Federal COVID Response-Audience Feedback To Inform Ongoing Messaging and Strategies for “Combat COVID”, 66321-66322 [2021-25413]
Download as PDF
<![CDATA[
66321
Federal Register / Vol. 86, No. 222 / Monday, November 22, 2021 / Notices
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group; Acquired Immunodeficiency
Syndrome Research Study Section.
Date: December 13, 2021.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F40A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Dimitrios Nikolaos
Vatakis, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, National Institute of
Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, MSC–
9823, Bethesda, MD 20892, (301) 761–7176,
dimitrios.vatakis@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 16, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–25335 Filed 11–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Federal COVID
Response—Audience Feedback To
Inform Ongoing Messaging and
Strategies for ‘‘Combat COVID’’
AGENCY:
National Institutes of Health,
HHS.
ACTION:
approval of the information collection
listed below.
Proposed Collection: Audience
Feedback to Inform Ongoing Messaging
and Strategies for ‘‘Combat COVID,’’
OMB #0925–0769, exp., date 12/31/
2021, EXTENSION National Institutes of
Health (NIH).
Need and Use of Information
Collection: The purpose of the
information collection is to collect
routine feedback from the Combat
COVID Initiative’s two target audiences
(the general public and healthcare
providers) to identify evolving needs
and better disseminate relevant
information as it relates to COVID–19
treatment and Accelerating COVID–19
Therapeutic Interventions and Vaccines
(ACTIV) clinical trial resources,
specifically. Data collected will be used
to inform the development and broad
dissemination of Combat COVID
resources, including new or enhanced
message and material concepts (e.g.,
social media ads, digital display ads,
out-of-home ads), and/or web pages
(combatcovid.hhs.gov). Because the
COVID–19 treatment landscape
continues to evolve, new evidencebased information continues to come to
the forefront, and audience needs
continue to change, it is critical for the
Federal COVID Response (FCR) Team to
collect quick audience feedback from
the general public (especially from
groups who have not historically been
well-represented in clinical trials) and
healthcare providers to identify these
evolving needs. By understanding target
audience needs, the FCR team will be
able to properly develop and broadly
disseminate relevant COVID–19
treatment and ACTIV clinical trial
resources. A change request was
recently submitted to update the recall
stimuli (still images, audio, and video or
animated images) for questions about
exposure to the Combat COVID message
and materials. It also removed questions
that are no longer relevant and replaced
them with more relevant questions
about the latest COVID–19 treatment
options and clinical trials.
OMB approval is requested for 1 year.
There are no costs to respondents other
than their time. The total estimated
annualized burden hours are 3,528.
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Ms. Mikia P.
Currie, Office of Policy for Extramural
Research Administration, 6705
Rockledge Drive, Suite 350, Bethesda,
Maryland 20892, or call a non-toll-free
number (301) 435–0941 or Email your
request, including your address to:
ProjectClearanceBranch@mail.nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on September 7, 2021, page
50143 (86 FR 50143) and allowed 60
days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Institutes of Health may not
conduct or sponsor, and the respondent
is not required to respond to, any
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
ADDRESSES:
jspears on DSK121TN23PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Consumer Audience Feedback Team Screener .............................................
HCP Audience Feedback Team Screener ......................................................
Consumer Audience Feedback Activity ...........................................................
HCP Audience Feedback Activity ....................................................................
VerDate Sep<11>2014
18:30 Nov 19, 2021
Jkt 256001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
120
40
60
20
E:\FR\FM\22NON1.SGM
1
1
8
8
22NON1
Average time
per response
(in hours)
5/60
5/60
1
1
Total annual
burden hours
10
3
480
160
66322
Federal Register / Vol. 86, No. 222 / Monday, November 22, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Form name
Average time
per response
(in hours)
Total annual
burden hours
Benchmark & Follow-Up Web Surveys—Consumer Audience .......................
Benchmark & Follow-Up Web Survey—HCP Audience ..................................
2,000
300
5
5
15/60
15/60
2,500
375
Total ..........................................................................................................
2,540
12,300
........................
3,528
Dated: November 16, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2021–25413 Filed 11–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Advisory Committee to
the Director, National Institutes of
Health.
These meetings will be held as virtual
meetings and are open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting, should notify the
Contact Person listed below in advance
of the meeting. The meetings will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
jspears on DSK121TN23PROD with NOTICES1
Number of
responses per
respondent
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: December 9, 2021.
Time: 12:00 p.m. to 6:05 p.m.
Agenda: NIH Director’s Report, Update on
COVID–19 Science, Other Business of the
Committee.
Place: National Institutes of Health,
Building 1, One Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: December 10, 2021.
Time: 12:00 p.m. to 5:15 p.m.
Agenda: ACD Working Group Updates,
Other Business of the Committee.
Place: National Institutes of Health,
Building 1, One Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–4272, Woodgs@od.nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
VerDate Sep<11>2014
18:30 Nov 19, 2021
Jkt 256001
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
acd.od.nih.gov, where an agenda and
any additional information for the
meeting will be posted when available.
This notice is being published less
than 15 days prior to the meeting due
to scheduling difficulties.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: November 17, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–25388 Filed 11–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Complementary and
Integrative Health.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
The meeting will be held as a virtual
meeting and is open to the public as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. The Open Session will
be open to the public via NIH Videocast.
The URL link to access this meeting is
https://videocast.nih.gov.
Name of Committee: National Advisory
Council for Complementary and Integrative
Health.
Date: January 21, 2022.
Closed: 10:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy 2, 6707 Democracy Boulevard,
Bethesda, MD 20817 (Virtual Meeting).
Open: 11:40 a.m. to 5:00 p.m.
Agenda: A report from the Director of the
Center and Other Staff.
Place: National Institutes of Health,
Democracy 2, 6707 Democracy Boulevard,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Partap Singh Khalsa,
Ph.D., DC, Director, Division of Extramural
Activities, National Center for
Complementary and Integrative Health,
National Institutes of Health, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20892–5475, 301–594–3462, khalsap@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person. Any
member of the public may submit written
comments no later than 15 days after the
meeting.
Information is also available on the
Institute’s/Center’s home page: https://
www.nccih.nih.gov/news/events/advisorycouncil-79th-meeting where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
E:\FR\FM\22NON1.SGM
22NON1
]]>Agencies
[Federal Register Volume 86, Number 222 (Monday, November 22, 2021)]
[Notices]
[Pages 66321-66322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-25413]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; Federal COVID
Response--Audience Feedback To Inform Ongoing Messaging and Strategies
for ``Combat COVID''
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Ms. Mikia P. Currie, Office of Policy for
Extramural Research Administration, 6705 Rockledge Drive, Suite 350,
Bethesda, Maryland 20892, or call a non-toll-free number (301) 435-0941
or Email your request, including your address to:
[email protected].
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on September 7, 2021, page
50143 (86 FR 50143) and allowed 60 days for public comment. No public
comments were received. The purpose of this notice is to allow an
additional 30 days for public comment. The National Institutes of
Health may not conduct or sponsor, and the respondent is not required
to respond to, any information collection that has been extended,
revised, or implemented on or after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: Audience Feedback to Inform Ongoing Messaging
and Strategies for ``Combat COVID,'' OMB #0925-0769, exp., date 12/31/
2021, EXTENSION National Institutes of Health (NIH).
Need and Use of Information Collection: The purpose of the
information collection is to collect routine feedback from the Combat
COVID Initiative's two target audiences (the general public and
healthcare providers) to identify evolving needs and better disseminate
relevant information as it relates to COVID-19 treatment and
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
clinical trial resources, specifically. Data collected will be used to
inform the development and broad dissemination of Combat COVID
resources, including new or enhanced message and material concepts
(e.g., social media ads, digital display ads, out-of-home ads), and/or
web pages (combatcovid.hhs.gov). Because the COVID-19 treatment
landscape continues to evolve, new evidence-based information continues
to come to the forefront, and audience needs continue to change, it is
critical for the Federal COVID Response (FCR) Team to collect quick
audience feedback from the general public (especially from groups who
have not historically been well-represented in clinical trials) and
healthcare providers to identify these evolving needs. By understanding
target audience needs, the FCR team will be able to properly develop
and broadly disseminate relevant COVID-19 treatment and ACTIV clinical
trial resources. A change request was recently submitted to update the
recall stimuli (still images, audio, and video or animated images) for
questions about exposure to the Combat COVID message and materials. It
also removed questions that are no longer relevant and replaced them
with more relevant questions about the latest COVID-19 treatment
options and clinical trials.
OMB approval is requested for 1 year. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 3,528.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Form name Number of responses per per response Total annual
respondents respondent (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
Consumer Audience Feedback Team Screener........ 120 1 5/60 10
HCP Audience Feedback Team Screener............. 40 1 5/60 3
Consumer Audience Feedback Activity............. 60 8 1 480
HCP Audience Feedback Activity.................. 20 8 1 160
[[Page 66322]]
Benchmark & Follow-Up Web Surveys--Consumer 2,000 5 15/60 2,500
Audience.......................................
Benchmark & Follow-Up Web Survey--HCP Audience.. 300 5 15/60 375
---------------------------------------------------------------
Total....................................... 2,540 12,300 .............. 3,528
----------------------------------------------------------------------------------------------------------------
Dated: November 16, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-25413 Filed 11-19-21; 8:45 am]
BILLING CODE 4140-01-P
